Cargando…

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study

BACKGROUND: A recently published genome-wide association study (GWAS) of late-onset Alzheimer's disease (LOAD) revealed genome-wide significant association of variants in or near MS4A4A, CD2AP, EPHA1 and CD33. Meta-analyses of this and a previously published GWAS revealed significant associatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrasquillo, Minerva M, Belbin, Olivia, Hunter, Talisha A, Ma, Li, Bisceglio, Gina D, Zou, Fanggeng, Crook, Julia E, Pankratz, V Shane, Sando, Sigrid B, Aasly, Jan O, Barcikowska, Maria, Wszolek, Zbigniew K, Dickson, Dennis W, Graff-Radford, Neill R, Petersen, Ronald C, Passmore, Peter, Morgan, Kevin, Younkin, Steven G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157442/ https://www.ncbi.nlm.nih.gov/pubmed/21798052 http://dx.doi.org/10.1186/1750-1326-6-54

Ejemplares similares

Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility
por: Sevlever, Daniel, et al.
Publicado: (2015)

Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility
por: Sevlever, Daniel, et al.
Publicado: (2015)

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014)

Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology
por: Zou, Fanggeng, et al.
Publicado: (2013)

Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease
por: Belbin, Olivia, et al.
Publicado: (2010)

LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)
por: Lincoln, Sarah, et al.
Publicado: (2013)

Multiple Insulin Degrading Enzyme Variants Alter In Vitro Reporter Gene Expression
por: Belbin, Olivia, et al.
Publicado: (2011)

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
por: Allen, Mariet, et al.
Publicado: (2012)

Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants
por: Zou, Fanggeng, et al.
Publicado: (2012)

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
por: Finch, NiCole, et al.
Publicado: (2009)

Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases
por: Allen, Mariet, et al.
Publicado: (2016)

Evaluation of the Role of SNCA Variants in Survival without Neurological Disease
por: Heckman, Michael G., et al.
Publicado: (2012)

Late-onset Alzheimer disease risk variants mark brain regulatory loci
por: Allen, Mariet, et al.
Publicado: (2015)

Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease
por: Carrasquillo, Minerva M., et al.
Publicado: (2010)

Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease
por: Hollingworth, Paul, et al.
Publicado: (2011)

Latent trait modeling of tau neuropathology in progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2021)

EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer
por: Nikas, Ilias, et al.
Publicado: (2022)

Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson’s Disease Locus
por: Labbé, Catherine, et al.
Publicado: (2015)

Rheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease
por: Simmons, Christopher R, et al.
Publicado: (2011)

Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk
por: Simmons, Christopher R, et al.
Publicado: (2011)

EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia
por: Pergaris, Alexandros, et al.
Publicado: (2022)

Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy
por: Sakae, Nobutaka, et al.
Publicado: (2019)

Plasma Biomarkers of Alzheimer’s Disease in African Americans
por: Deniz, Kaancan, et al.
Publicado: (2021)

African American exome sequencing identifies potential risk variants at Alzheimer disease loci
por: N'Songo, Aurelie, et al.
Publicado: (2017)

Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains
por: Ma, Li, et al.
Publicado: (2016)

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
por: Conway, Olivia J, et al.
Publicado: (2018)

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
por: Strickland, Samantha L., et al.
Publicado: (2020)

Clinical and pathologic features of cognitive-predominant corticobasal degeneration
por: Sakae, Nobutaka, et al.
Publicado: (2020)

ABCA7 loss-of-function variants, expression, and neurologic disease risk
por: Allen, Mariet, et al.
Publicado: (2017)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease
por: Naj, Adam C, et al.
Publicado: (2011)

Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans
por: Reddy, Joseph S., et al.
Publicado: (2022)

A Dimerized HMX1 Inhibits EPHA6/epha4b in Mouse and Zebrafish Retinas
por: Marcelli, Fabienne, et al.
Publicado: (2014)

Ethnoracial differences in Alzheimer’s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort
por: Santos, Octavio A., et al.
Publicado: (2019)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j066meovasn2fr939kdocdslgi